The Neuromuscular Disease Network for Canada

funder-logos_nmd4c

CPD-accredited webinar | Diagnostic techniques for genetic neuromuscular diseases

NMD4C and Muscular Dystrophy Canada (MDC) are pleased to invite you to a webinar on diagnostic techniques for genetic neuromuscular diseases.

This webinar is CPD-accredited. The NMD Rounds & Educational Webinars is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

This webinar is primarily targeted at Canadian clinicians, academics and trainees with an interest in neuromuscular disease. NMD4C and MDC are providing organizational and technical support, and this is an independent clinical/academic webinar with no industry sponsorship.

Tuesday, November 3rd at 5:00pm EST

If you have any questions, please email


Register HERE


Agenda:

  1. Muscle MRI transforming care and research in genetic muscle diseaseDr. Jodi Warman Chardon (NMD4C Steering Committee member)
  2. Use of Ultrasound in Pediatric Neuromuscular Disorders — Dr. Jean Mah
  3. Still Gold: the Ongoing Need for Muscle Biopsies in the Molecular Age — Dr. Leslie Hamilton (NMD4C member)

Learning objectives:

  1. Highlight diagnostic techniques (Muscle Biopsy, Neuromuscular Ultrasound, Muscle MRI) to improve phenotyping for patients with genetic neuromuscular disease
  2. Develop a biopsy-based diagnostic approach in the genomics era with myopathies/muscular dystrophies
  3. Recognize clinical applications of neuromuscular ultrasound and diagnostic value in muscle and nerve disorders
  4. Identify Muscle MRI patterns to guide genetic testing interpretation and myopathy mimics
Diagnostic-Techniques-Genetic-Neuromuscular-Diseases-Register-Now-1200x1200

Read next...

logos-treat-nmd-logo

NMD4C steering committee member Dr. Jim Dowling appointed Chair of the executive committee of TREAT-NMD

The NMD4C would like to congratulate our Steering Committee member Dr. Jim Dowling on his appointment as Chair of the executive committee of TREAT-NMD!

ENMC logo topkwaliteit

Launch of ENMC Mid-Career Mentoring Programme

Building from the success of the ENMC Early-Career Programme, the ENMC is proud to launch a new and ambitious Mid-Career Mentoring Programme.

image001

Rare Disease Day 2021 Recap

Observed annually on the last day of February, Rare Disease Day seeks to raise awareness among the general public, as well as policymakers, public authorities, industry representatives, scientists, and health professionals.   Due to the COVID-19 pandemic, activities this year were mainly virtual. But that did not stop patients, caregivers, researchers, clinicians, advocates and patient…

International DM day announced

International Myotonic Dystrophy Awareness Day Declared for September 15, 2021

The NMD4C are proud to be a part of a global alliance of myotonic dystrophy-focused organisations who in honour of Rare Disease Day 2021 have united to announce the declaration of International Myotonic Dystrophy Awareness Day to be observed each September 15th.

vaccine_stock

MDC Press Release | Muscular Dystrophy Canada calls on provincial governments to prioritize persons affected by neuromuscular disorders for COVID-19 vaccine

As the voice of the NMD community in Canada, Muscular Dystrophy Canada (MDC) is calling on governments to prioritize people living with hereditary and acquired neuromuscular disorders in their vaccination roll-out.

Ask the Experts COVID 19

Webinar, FAQ Report & Decision Aid | COVID-19 & Neuromuscular Disorders: Ask The Experts

Muscular Dystrophy Canada (MDC) and the Neuromuscular Disease Network for Canada (NMD4C) have received numerous questions about COVID-19 vaccines and how they may uniquely affect people with neuromuscular disorders (NMD). To address these questions and concerns, MDC & NMD4C assembled a diverse group of neuromuscular, virology, and policy experts to host a webinar with the…